<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-13T21:59:04Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/jgro.000030">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/jgro.000030</identifier>
									<datestamp>2017-03-03</datestamp>
									<setSpec>PTZ.JGRO:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Effect of Intrauterine Infusion of Granulocyte Colony Stimulating Factor on IVF Outcomes in Infertile Women
										</dc:title><dc:creator>Mostafa F</dc:creator><dc:creator>Farid L</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Objective:&lt;/strong&gt; The primary goal of this study was to assess the G-CSF effects on IVF outcomes in women
with normal endometrial thickness.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients and Methods:&lt;/strong&gt; This was a randomized controlled study performed at Assisted Reproductive
Techniques Center of Ain Shams University Maternity Hospital, over a 2-year period, between Jan 2014 and
Jan 2016, and included 60 infertile women with normal endometrial thickness. Women were scheduled
for IVF and randomized into two groups. Exclusion criteria were positive history of repeated implantation
failure (RIF), endocrine disorders, severe endometriosis, congenital or acquired uterine anomaly and
contraindication for G-CSF (renal disease, sickle cell disease, or malignancy). In G-CSF group (n=30), 300
μg trans-cervical intrauterine of G-CSF was administered at the oocyte retrieval day. Controls (n=30) were
treated with standard protocol. Chemical, clinical and ongoing pregnancy rates, implantation rate, and
miscarriage rate were compared between groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; Biochemical pregnancy had occurred in 27.3% of participants in group I and 21.3% of women
in group II with a significant difference between the two groups. The clinical pregnancy rate was 22% and
16% in group I and II respectively with no significant difference between the two groups. The acceptability
of women in group I was 68%, mild discomfort occurred in 44.7%, moderate discomfort was in 28.7%,
severe discomfort was in 11.3% and 15.3% of women in group I had no discomfort at all. Difficult flushing
had occurred in 14.7% of women.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; It looks that the clinical pregnancy rates were significantly higher by intracavitary
infusion of granulocyte colony stimulating factor&lt;/p&gt;</dc:description>
										<dc:publisher>Journal of Gynecological Research and Obstetrics - Peertechz Publications</dc:publisher>
										<dc:date>2017-03-03</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/jgro.000030</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Mostafa F et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
